VBI Vaccines Inc. (VBIV)
NASDAQ: VBIV
· Real-Time Price · USD
0.07
-0.06 (-47.33%)
At close: Aug 07, 2024, 8:00 PM
-47.33% (1D)
| Bid | n/a |
| Market Cap | 1.87M |
| Revenue (ttm) | 9.41M |
| Net Income (ttm) | -82.98M |
| EPS (ttm) | -3.54 |
| PE Ratio (ttm) | -0.01844632768361582 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 27,931,464 |
| Avg. Volume (20D) | 8,393,583 |
| Open | 0.09 |
| Previous Close | 0.13 |
| Day's Range | 0.06 - 0.09 |
| 52-Week Range | 0.06 - 1.35 |
| Beta | 2.17 |
About VBIV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VBIV
Website n/a
10 months ago
VBI Vaccines shares are trading higher on volatili...
Unlock content with
Pro Subscription
10 months ago
VBI Vaccines shares are trading lower after the company was granted protection under Canada's CCAA by the Ontario Superior Court. The company received approval for a DIP loan, and Ernst & Young was appointed as the monitor during the restructuring process.